Clinical Trials on Multiple Disability in New Zealand
Total 1557 results
-
Hoffmann-La RocheRecruitingMultiple MyelomaBelgium, Korea, Republic of, Denmark, United Kingdom, Australia, New Zealand, Italy, Spain, France
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
IMS HEALTH GmbH & Co. OHGEMD SeronoCompletedRelapsing-remitting Multiple SclerosisUnited States, Canada
-
Regeneron PharmaceuticalsActive, not recruitingRelapsed and Refractory Multiple Myeloma (RRMM)United States
-
Roswell Park Cancer InstituteTerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Rutgers, The State University of New JerseyCompletedMultiple SclerosisUnited States
-
Rutgers, The State University of New JerseyCompletedMultiple SclerosisUnited States
-
NovartisCompletedMultiple SclerosisUnited States, Turkey, Romania, United Kingdom, Poland, Austria, Canada, Australia
-
Universitätsklinikum KölnWuerzburg University Hospital; Universitätsklinikum LeipzigCompletedMultiple TraumaGermany
-
Novartis PharmaceuticalsTerminatedRelapsing-remitting Multiple Sclerosis (RRMS)United States, Canada, Mexico, Brazil, Puerto Rico, Argentina, Chile
-
Jersey Shore University Medical CenterRutgers University; Rutgers Cancer Institute of New JerseyCompletedPancreatic Cancer | Parathyroid Disease | Thymic Cancer | MEN1 SyndromeUnited States
-
Hoffmann-La RochePPDRecruitingRelapsing-Remitting Multiple SclerosisUnited States, Belgium, Canada, Spain, India, Italy, Mexico, Portugal, Argentina, Austria, Brazil, United Kingdom, Germany, Netherlands, Serbia, Australia, Bulgaria, France, Greece, Hungary, Poland, Ukraine, Estonia, Denmark, Croatia, Latvia and more
-
University of RochesterAmgenActive, not recruiting
-
Roswell Park Cancer InstituteCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Jagannath, Sundar, M.D.Unicorn Pacific CorporationTerminatedMultiple MyelomaUnited States
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisSweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited States, Puerto Rico
-
Travera IncMassachusetts General Hospital; Dana-Farber Cancer Institute; Weill Medical College... and other collaboratorsRecruitingMultiple Myeloma in RelapseUnited States
-
BiogenAlkermes, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Poland
-
Lenetix Medical Screening LaboratoryUnknownDown Syndrome (Trisomy 21) | Edward's Syndrome (Trisomy 18) | Patau Syndrome (Trisomy 13) | Klinefelter Syndrome (47, XXY) | and Other Chromosome | Abnormalities.United States
-
National Cancer Institute (NCI)CompletedRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Genzyme, a Sanofi CompanyTerminatedRelapsing-remitting Multiple SclerosisSweden, Poland, Russian Federation, United States, Canada
-
University of RochesterKaryopharm Therapeutics IncRecruitingSmoldering Multiple MyelomaUnited States
-
Roswell Park Cancer InstituteCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
SanofiCompletedRelapsing Multiple SclerosisIndia
-
University of RochesterRecruitingMultiple Myeloma | Prostate Cancer | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple Myeloma (SMM)United States
-
Suhayl Dhib-Jalbut, MDEnrolling by invitation
-
Rutgers, The State University of New JerseyBayerCompletedMultiple SclerosisUnited States
-
Harpoon TherapeuticsActive, not recruitingMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma of BoneUnited States, Spain, France
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
NYU Langone HealthUnicorn Pacific CorporationTerminatedMyelomaUnited States
-
Helius Medical IncRecruitingGait Impairment Due to Mild/Moderate Multiple Sclerosis (MS)United States
-
Brainstorm-Cell TherapeuticsCompletedMultiple Sclerosis, Chronic ProgressiveUnited States
-
Yale UniversityTerminatedAsymptomatic MyelomaUnited States
-
Icahn School of Medicine at Mount SinaiResearch Foundation for Mental Hygiene, Inc.; Autism Science Foundation; The...RecruitingAutism Spectrum Disorder | FOXP1 | Mental Retardation With Language Impairment and With or Without Autistic FeaturesUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Bristol-Myers SquibbCompleted
-
Millennium Pharmaceuticals, Inc.CompletedWaldenstrom Macroglobulinemia | Refractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
EMD SeronoMerck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. LtdTerminatedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Japan, Poland, Russian Federation, Spain, Ukraine, Greece
-
Genta IncorporatedCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
BiogenCompleted
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisAustralia
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
National Cancer Institute (NCI)Georgetown University; Hackensack Meridian HealthTerminatedMyeloma-Multiple | Myeloma, Plasma-Cell | MyelomatosisUnited States
-
Fortis Therapeutics, Inc.CompletedMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed RemissionUnited States
-
Multiple Myeloma Research ConsortiumBristol-Myers Squibb; Memorial Sloan Kettering Cancer Center; Washington University... and other collaboratorsActive, not recruitingMultiple Myeloma | Relapsed Refractory Multiple MyelomaUnited States
-
University of Maryland, BaltimoreNational Cancer Institute (NCI); University of Maryland Greenebaum Cancer CenterCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
National Cancer Institute (NCI)RecruitingPlasmacytoma | Refractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Rutgers, The State University of New JerseyHorizon Blue Cross Blue Shield of New JerseyRecruitingMultiple Sclerosis | Cognitive ImpairmentUnited States